195 related articles for article (PubMed ID: 28079159)
21. Lead induces chondrogenesis and alters transforming growth factor-beta and bone morphogenetic protein signaling in mesenchymal cell populations.
Zuscik MJ; Ma L; Buckley T; Puzas JE; Drissi H; Schwarz EM; O'Keefe RJ
Environ Health Perspect; 2007 Sep; 115(9):1276-82. PubMed ID: 17805416
[TBL] [Abstract][Full Text] [Related]
22. IFN-alpha-induced signal transduction, gene expression, and antitumor activity of immune effector cells are negatively regulated by suppressor of cytokine signaling proteins.
Zimmerer JM; Lesinski GB; Kondadasula SV; Karpa VI; Lehman A; Raychaudhury A; Becknell B; Carson WE
J Immunol; 2007 Apr; 178(8):4832-45. PubMed ID: 17404264
[TBL] [Abstract][Full Text] [Related]
23. Inhibiting the MNK1/2-eIF4E axis impairs melanoma phenotype switching and potentiates antitumor immune responses.
Huang F; Gonçalves C; Bartish M; Rémy-Sarrazin J; Issa ME; Cordeiro B; Guo Q; Emond A; Attias M; Yang W; Plourde D; Su J; Gimeno MG; Zhan Y; Galán A; Rzymski T; Mazan M; Masiejczyk M; Faber J; Khoury E; Benoit A; Gagnon N; Dankort D; Journe F; Ghanem GE; Krawczyk CM; Saragovi HU; Piccirillo CA; Sonenberg N; Topisirovic I; Rudd CE; Miller WH; Del Rincón SV
J Clin Invest; 2021 Apr; 131(8):. PubMed ID: 33690225
[TBL] [Abstract][Full Text] [Related]
24. Up-regulation of PD-L1, IDO, and T(regs) in the melanoma tumor microenvironment is driven by CD8(+) T cells.
Spranger S; Spaapen RM; Zha Y; Williams J; Meng Y; Ha TT; Gajewski TF
Sci Transl Med; 2013 Aug; 5(200):200ra116. PubMed ID: 23986400
[TBL] [Abstract][Full Text] [Related]
25. ILT4 inhibition prevents TAM- and dysfunctional T cell-mediated immunosuppression and enhances the efficacy of anti-PD-L1 therapy in NSCLC with EGFR activation.
Chen X; Gao A; Zhang F; Yang Z; Wang S; Fang Y; Li J; Wang J; Shi W; Wang L; Zheng Y; Sun Y
Theranostics; 2021; 11(7):3392-3416. PubMed ID: 33537094
[No Abstract] [Full Text] [Related]
26. eEF2K promotes PD-L1 stabilization through inactivating GSK3β in melanoma.
Chen X; Wang K; Jiang S; Sun H; Che X; Zhang M; He J; Wen Y; Liao M; Li X; Zhou X; Song J; Ren X; Yi W; Yang J; Chen X; Yin M; Cheng Y
J Immunother Cancer; 2022 Mar; 10(3):. PubMed ID: 35347072
[TBL] [Abstract][Full Text] [Related]
27. Polymer nanoparticles for enhanced immune response: combined delivery of tumor antigen and small interference RNA for immunosuppressive gene to dendritic cells.
Heo MB; Cho MY; Lim YT
Acta Biomater; 2014 May; 10(5):2169-76. PubMed ID: 24394635
[TBL] [Abstract][Full Text] [Related]
28. Amplifying IFN-γ Signaling in Dendritic Cells by CD11c-Specific Loss of SOCS1 Increases Innate Immunity to Infection while Decreasing Adaptive Immunity.
Alice AF; Kramer G; Bambina S; Baird JR; Bahjat KS; Gough MJ; Crittenden MR
J Immunol; 2018 Jan; 200(1):177-185. PubMed ID: 29150567
[TBL] [Abstract][Full Text] [Related]
29. Trastuzumab upregulates PD-L1 as a potential mechanism of trastuzumab resistance through engagement of immune effector cells and stimulation of IFNγ secretion.
Chaganty BKR; Qiu S; Gest A; Lu Y; Ivan C; Calin GA; Weiner LM; Fan Z
Cancer Lett; 2018 Aug; 430():47-56. PubMed ID: 29746929
[TBL] [Abstract][Full Text] [Related]
30. WNT1-inducible signaling pathway protein 1 (WISP1/CCN4) stimulates melanoma invasion and metastasis by promoting the epithelial-mesenchymal transition.
Deng W; Fernandez A; McLaughlin SL; Klinke DJ
J Biol Chem; 2019 Apr; 294(14):5261-5280. PubMed ID: 30723155
[TBL] [Abstract][Full Text] [Related]
31. Pim-3 enhances melanoma cell migration and invasion by promoting STAT3 phosphorylation.
Liu J; Qu X; Shao L; Hu Y; Yu X; Lan P; Guo Q; Han Q; Zhang J; Zhang C
Cancer Biol Ther; 2018 Mar; 19(3):160-168. PubMed ID: 29370558
[TBL] [Abstract][Full Text] [Related]
32. The canonical TGF-β/Smad signalling pathway is involved in PD-L1-induced primary resistance to EGFR-TKIs in EGFR-mutant non-small-cell lung cancer.
Zhang Y; Zeng Y; Liu T; Du W; Zhu J; Liu Z; Huang JA
Respir Res; 2019 Jul; 20(1):164. PubMed ID: 31331328
[TBL] [Abstract][Full Text] [Related]
33. [miR-155-5p alleviates lipopolysaccharide-induced inflammatory damage of human SH-SY5Y neuroblastoma cells by down-regulating SOCS1].
Zhou H; Zhou L; Zhang C; Zhou L; Han Y
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2023 Mar; 39(3):220-229. PubMed ID: 36946346
[TBL] [Abstract][Full Text] [Related]
34. A lipid-soluble extract of Pinellia pedatisecta Schott orchestrates intratumoral dendritic cell-driven immune activation through SOCS1 signaling in cervical cancer.
Wang Y; Lu C; Huang H; Yao S; Xu C; Ye Y; Gui S; Li G
J Ethnopharmacol; 2021 Mar; 267():112837. PubMed ID: 32276009
[TBL] [Abstract][Full Text] [Related]
35. Cyano Enone-Bearing Triterpenoid Soloxolone Methyl Inhibits Epithelial-Mesenchymal Transition of Human Lung Adenocarcinoma Cells In Vitro and Metastasis of Murine Melanoma In Vivo.
Markov AV; Odarenko KV; Sen'kova AV; Salomatina OV; Salakhutdinov NF; Zenkova MA
Molecules; 2020 Dec; 25(24):. PubMed ID: 33327637
[TBL] [Abstract][Full Text] [Related]
36. A TCM formula comprising Sophorae Flos and Lonicerae Japonicae Flos alters compositions of immune cells and molecules of the STAT3 pathway in melanoma microenvironment.
Liu YX; Bai JX; Li T; Fu XQ; Guo H; Zhu PL; Chan YC; Chou JY; Yin CL; Li JK; Wang YP; Chen YJ; Yu ZL
Pharmacol Res; 2019 Apr; 142():115-126. PubMed ID: 30797070
[TBL] [Abstract][Full Text] [Related]
37. RON Receptor Tyrosine Kinase Regulates Epithelial Mesenchymal Transition and the Expression of Pro-Fibrotic Markers via Src/Smad Signaling in HK-2 and NRK49F Cells.
Park JS; Choi HI; Kim DH; Kim CS; Bae EH; Ma SK; Kim SW
Int J Mol Sci; 2019 Nov; 20(21):. PubMed ID: 31690042
[TBL] [Abstract][Full Text] [Related]
38. Nanoparticle-delivered transforming growth factor-β siRNA enhances vaccination against advanced melanoma by modifying tumor microenvironment.
Xu Z; Wang Y; Zhang L; Huang L
ACS Nano; 2014 Apr; 8(4):3636-45. PubMed ID: 24580381
[TBL] [Abstract][Full Text] [Related]
39. Epithelial-mesenchymal-transition-like and TGFβ pathways associated with autochthonous inflammatory melanoma development in mice.
Wehbe M; Soudja SM; Mas A; Chasson L; Guinamard R; de Tenbossche CP; Verdeil G; Van den Eynde B; Schmitt-Verhulst AM
PLoS One; 2012; 7(11):e49419. PubMed ID: 23173060
[TBL] [Abstract][Full Text] [Related]
40. Intratumoral Delivery of an Adenoviral Vector Carrying the
Nakagawa S; Serada S; Kakubari R; Hiramatsu K; Sugase T; Matsuzaki S; Matsuzaki S; Ueda Y; Yoshino K; Ohkawara T; Fujimoto M; Kishimoto T; Kimura T; Naka T
Mol Cancer Ther; 2018 Sep; 17(9):1941-1950. PubMed ID: 29891489
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
